CMEswiper: GLP-1s in a Flash! Swiping Through Barriers in Psoriasis Care: An Online Activity

Section cover
Released on
May 21, 2026
Earn up to
0.25 AMA PRA Category 1 Credit(s)™

CMEswiper: GLP-1s in a Flash! Swiping Through Barriers in Psoriasis Care: An Online Activity

This activity is supported by an educational grant from Lilly.

Psoriasis and metabolic disease are increasingly interconnected—and treatment conversations are evolving alongside them. This interactive, mobile-friendly CMEswiper experience highlights the growing role of GLP-1 therapies in delivering more comprehensive, patient-centered care for individuals with psoriasis and overweight/obesity.

‘Swipe’ and ‘tap’ or ‘click’ at your own speed through concise clinical insights with expert commentary throughout the activity.

“Psoriasis and obesity are interconnected through shared inflammatory pathways, so addressing metabolic health isn’t separate from treating the skin—it’s part of the same strategy.” - Tina Bhutani, MD, MAS, FAAD